这是一篇来自已证抗体库的有关小鼠 DX5的综述,是根据149篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合DX5 抗体。
DX5 同义词: CD49B; DX5; GPIa

BioLegend
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s3
BioLegend DX5抗体(BioLegend, 108909)被用于被用于流式细胞仪在小鼠样本上 (图 s3). J Clin Invest (2022) ncbi
仓鼠 单克隆(HMα2)
  • 流式细胞仪; 小鼠; 图 2a
BioLegend DX5抗体(BioLegend, 103515)被用于被用于流式细胞仪在小鼠样本上 (图 2a). Sci Adv (2022) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:200; 图 s6c
BioLegend DX5抗体(Biolegend, 108905)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 s6c). J Immunother Cancer (2022) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 2b, 4c
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 2b, 4c). Basic Res Cardiol (2022) ncbi
大鼠 单克隆(DX5)
  • 免疫组化-石蜡切片; 小鼠; 1:50; 图 1f
BioLegend DX5抗体(BioLegend, 108902)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50 (图 1f). Br J Cancer (2022) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:40; 图 6e
BioLegend DX5抗体(Biolegend, 108926)被用于被用于流式细胞仪在小鼠样本上浓度为1:40 (图 6e). Proc Natl Acad Sci U S A (2022) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:100
BioLegend DX5抗体(Biolegend, 108907)被用于被用于流式细胞仪在小鼠样本上浓度为1:100. Nat Nanotechnol (2022) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上. Front Immunol (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:200; 图 5e
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 5e). Cancer Res (2021) ncbi
仓鼠 单克隆(HMα2)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(Biolegend, 103501)被用于被用于流式细胞仪在小鼠样本上. Cancer Cell (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(Biolegend, DX-5)被用于被用于流式细胞仪在小鼠样本上. Adv Sci (Weinh) (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:100; 图 s7a
BioLegend DX5抗体(BioLegend, 108910)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 s7a). Nat Commun (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上. J Reprod Immunol (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:300; 图 s9h
BioLegend DX5抗体(BioLegend, 108918)被用于被用于流式细胞仪在小鼠样本上浓度为1:300 (图 s9h). Nature (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s4
BioLegend DX5抗体(Biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s4). J Immunother Cancer (2021) ncbi
大鼠 单克隆(DX5)
BioLegend DX5抗体(Biolegend, 108906)被用于. Theranostics (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(BioLegend, 108904)被用于被用于流式细胞仪在小鼠样本上. J Clin Invest (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(Biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上. Antioxidants (Basel) (2020) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1c
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 1c). Am J Transplant (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1a
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Sci Adv (2020) ncbi
大鼠 单克隆(DX5)
BioLegend DX5抗体(BioLegend, 108909)被用于. Nat Commun (2020) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:100; 图 5e
BioLegend DX5抗体(BioLegend, 108909)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 5e). Proc Natl Acad Sci U S A (2020) ncbi
仓鼠 单克隆(HMα2)
  • mass cytometry; 小鼠; 0.1875 ug/ml; 图 5d
BioLegend DX5抗体(Biolegend, HM??2)被用于被用于mass cytometry在小鼠样本上浓度为0.1875 ug/ml (图 5d). Science (2019) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s2a
BioLegend DX5抗体(Biolegend, 108906)被用于被用于流式细胞仪在小鼠样本上 (图 s2a). JCI Insight (2019) ncbi
仓鼠 单克隆(HMα2)
  • 流式细胞仪; 小鼠; 图 s14b
BioLegend DX5抗体(Biolegend, 103518)被用于被用于流式细胞仪在小鼠样本上 (图 s14b). J Clin Invest (2019) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:100; 图 5c
BioLegend DX5抗体(BioLegend, 108910)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 5c). Nat Commun (2019) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 3i
BioLegend DX5抗体(Biolegend, 108922)被用于被用于流式细胞仪在小鼠样本上 (图 3i). Sci Rep (2019) ncbi
仓鼠 单克隆(HMα2)
  • 流式细胞仪; 小鼠; 图 s13a
BioLegend DX5抗体(Biolegend, 103515)被用于被用于流式细胞仪在小鼠样本上 (图 s13a). Science (2018) ncbi
仓鼠 单克隆(HMα2)
  • 流式细胞仪; 小鼠; 图 3d
BioLegend DX5抗体(BioLegend, HMa2)被用于被用于流式细胞仪在小鼠样本上 (图 3d). J Cell Biol (2018) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 3b
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 3b). Front Immunol (2018) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s4b
BioLegend DX5抗体(Biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s4b). J Biol Chem (2018) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s1
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s1). Front Microbiol (2018) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 3
BioLegend DX5抗体(Biolegend, 108908)被用于被用于流式细胞仪在小鼠样本上 (图 3). Sci Rep (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1b
BioLegend DX5抗体(biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 1b). J Exp Med (2017) ncbi
大鼠 单克隆(DX5)
  • 其他; 小鼠; 图 s2a
BioLegend DX5抗体(BioLegend, DX5)被用于被用于其他在小鼠样本上 (图 s2a). J Clin Invest (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 4a
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 4a). JCI Insight (2017) ncbi
仓鼠 单克隆(HMα2)
  • 免疫组化; 小鼠; 图 2j
BioLegend DX5抗体(Biolegend, 103521)被用于被用于免疫组化在小鼠样本上 (图 2j). Cell Stem Cell (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 st4
BioLegend DX5抗体(Biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 st4). Nature (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:100; 图 s2a
BioLegend DX5抗体(Biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 s2a). J Exp Med (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:200; 图 1a
BioLegend DX5抗体(BioLegend, Dx5)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 1a). Nat Commun (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s3a
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s3a). Nat Commun (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 5a
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 5a). J Virol (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上. J Virol (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(Biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上. J Clin Invest (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:200; 表 1
BioLegend DX5抗体(Biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (表 1). Nat Commun (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(Biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上. J Neuroimmunol (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 2
BioLegend DX5抗体(Biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 2). PLoS ONE (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1
BioLegend DX5抗体(Biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 1). Mucosal Immunol (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 4B
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 4B). J Exp Med (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 1). Theranostics (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 6
BioLegend DX5抗体(BioLegend, 108921)被用于被用于流式细胞仪在小鼠样本上 (图 6). Oncotarget (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 4
BioLegend DX5抗体(Biolegend, DX-5)被用于被用于流式细胞仪在小鼠样本上 (图 4). Mucosal Immunol (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(Biolegend, 108910)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:400; 图 s2
BioLegend DX5抗体(BioLegend, 108908)被用于被用于流式细胞仪在小鼠样本上浓度为1:400 (图 s2). Nat Commun (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s1
BioLegend DX5抗体(biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s1). Immunity (2015) ncbi
仓鼠 单克隆(HMα2)
  • 流式细胞仪; 小鼠; 图 2
BioLegend DX5抗体(Biolegend, 103506)被用于被用于流式细胞仪在小鼠样本上 (图 2). Stem Cell Reports (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(Biolegend, DX5)被用于被用于流式细胞仪在小鼠样本上. Oncotarget (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(BioLegend, 108921)被用于被用于流式细胞仪在小鼠样本上. Anticancer Res (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2014) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (2014) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s2
BioLegend DX5抗体(BioLegend, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s2). J Immunol (2014) ncbi
赛默飞世尔
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:1000
赛默飞世尔 DX5抗体(Invitrogen, 17-5971-81)被用于被用于流式细胞仪在小鼠样本上浓度为1:1000. Theranostics (2022) ncbi
家羊 多克隆
  • 免疫组化-冰冻切片; 小鼠; 1:25; 图 3a
赛默飞世尔 DX5抗体(Thermo Fisher, PA5-47193)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:25 (图 3a). J Pathol (2022) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s3
赛默飞世尔 DX5抗体(Thermo Fisher, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s3). Cell Death Dis (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(Invitrogen, 485971-82)被用于被用于流式细胞仪在小鼠样本上. J Clin Invest (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:200; 图 1a, 6a, 6s1a, 7s1a
赛默飞世尔 DX5抗体(ThermoFisher, 11-5971-85)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 1a, 6a, 6s1a, 7s1a). elife (2020) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:200; 图 s3d, 7b
赛默飞世尔 DX5抗体(eBioscience, DX5;25-5971-82)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 s3d, 7b). Sci Immunol (2020) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1 ug/ml; 图 s12
赛默飞世尔 DX5抗体(Invitrogen, 12-5971-82)被用于被用于流式细胞仪在小鼠样本上浓度为1 ug/ml (图 s12). Science (2019) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:500; 图 5a
赛默飞世尔 DX5抗体(eBioscience, 17-5971)被用于被用于流式细胞仪在小鼠样本上浓度为1:500 (图 5a). Cell (2019) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:200
赛默飞世尔 DX5抗体(ebioscience, DX5)被用于被用于流式细胞仪在小鼠样本上浓度为1:200. Nature (2018) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s1c
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s1c). Front Immunol (2018) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 3h
赛默飞世尔 DX5抗体(eBioscience, 17-5971-82)被用于被用于流式细胞仪在小鼠样本上 (图 3h). Science (2018) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s10d
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s10d). Science (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上. Am J Transplant (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 6
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 6). Sci Rep (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 2d
赛默飞世尔 DX5抗体(eBiosciences, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 2d). Cancer Res (2017) ncbi
仓鼠 单克隆(HMa2)
  • 流式细胞仪; 小鼠; 图 5a
赛默飞世尔 DX5抗体(eBioscience, 11-0491)被用于被用于流式细胞仪在小鼠样本上 (图 5a). J Cell Mol Med (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 2). J Exp Med (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1-s1
赛默飞世尔 DX5抗体(eBiosciences, 13-5971-85)被用于被用于流式细胞仪在小鼠样本上 (图 1-s1). elife (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:100
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上浓度为1:100. Nat Commun (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1d
赛默飞世尔 DX5抗体(eBiosciences, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 1d). J Exp Med (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 3). J Exp Med (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1e
赛默飞世尔 DX5抗体(Affymetrix/eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 1e). Oncoimmunology (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 DX5抗体(eBiosciences, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 2). Nat Immunol (2015) ncbi
仓鼠 单克隆(HMa2)
  • 流式细胞仪; 小鼠; 1:250; 图 3a
赛默飞世尔 DX5抗体(eBioscience,, HMa2)被用于被用于流式细胞仪在小鼠样本上浓度为1:250 (图 3a). J Immunol (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s1a
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s1a). Retrovirology (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, # 14-5971-85)被用于被用于流式细胞仪在小鼠样本上. Front Immunol (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 5
赛默飞世尔 DX5抗体(eBioscience, 12-5971-82)被用于被用于流式细胞仪在小鼠样本上 (图 5). Mar Drugs (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 1). Nat Immunol (2015) ncbi
仓鼠 单克隆(HMa2)
  • 流式细胞仪; 小鼠; 1:500
赛默飞世尔 DX5抗体(eBioscience, HMa2)被用于被用于流式细胞仪在小鼠样本上浓度为1:500. Nat Commun (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 6c
赛默飞世尔 DX5抗体(eBioscience, 11-5971-85)被用于被用于流式细胞仪在小鼠样本上 (图 6c). Shock (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s2
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s2). J Immunol (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, 48-5971-82)被用于被用于流式细胞仪在小鼠样本上. Eur J Immunol (2014) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上. Sci Rep (2014) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 5a
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 5a). PLoS ONE (2013) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2012) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上. Nat Immunol (2011) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 5
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 5). Immunol Cell Biol (2012) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 1). J Immunol (2010) ncbi
仓鼠 单克隆(HMa2)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, HMa2)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2010) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 1). J Immunol (2010) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 4). J Immunol (2009) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (2009) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(Caltag, DX5)被用于被用于流式细胞仪在小鼠样本上. Cell Tissue Res (2008) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上. Int Immunol (2006) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上. Proc Natl Acad Sci U S A (2006) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (2006) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
赛默飞世尔 DX5抗体(eBioscience, DX5)被用于被用于流式细胞仪在小鼠样本上. Proc Natl Acad Sci U S A (2005) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR17338)
  • 免疫印迹; 人类; 1:5000; 图 1e
艾博抗(上海)贸易有限公司 DX5抗体(Abcam, ab181548)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 1e). elife (2020) ncbi
domestic rabbit 单克隆(EPR17338)
  • 免疫印迹; 人类; 图 s4e, s4f
艾博抗(上海)贸易有限公司 DX5抗体(Abcam, ab181548)被用于被用于免疫印迹在人类样本上 (图 s4e, s4f). Cell (2019) ncbi
domestic rabbit 单克隆(EPR5788)
  • 免疫组化; 小鼠; 图 4b
  • 免疫印迹; 小鼠; 图 4c
艾博抗(上海)贸易有限公司 DX5抗体(Abcam, ab133557)被用于被用于免疫组化在小鼠样本上 (图 4b) 和 被用于免疫印迹在小鼠样本上 (图 4c). J Cell Mol Med (2017) ncbi
domestic rabbit 单克隆(EPR17338)
  • 免疫印迹; 人类; 图 3b
艾博抗(上海)贸易有限公司 DX5抗体(Abcam, ab181548)被用于被用于免疫印迹在人类样本上 (图 3b). J Biol Chem (2016) ncbi
domestic rabbit 单克隆(EPR5788)
  • 免疫细胞化学; 人类; 图 s3
  • 免疫印迹; 人类; 图 s5
艾博抗(上海)贸易有限公司 DX5抗体(Abcam, EPR5788)被用于被用于免疫细胞化学在人类样本上 (图 s3) 和 被用于免疫印迹在人类样本上 (图 s5). Nat Struct Mol Biol (2016) ncbi
domestic rabbit 单克隆(EPR5788)
  • 免疫印迹; 人类; 1:10,000; 图 2
艾博抗(上海)贸易有限公司 DX5抗体(Abcam, ab133557)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 2). Nature (2015) ncbi
美天旎
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
美天旎 DX5抗体(Miltenyi Biotec, 130-123-702)被用于被用于流式细胞仪在小鼠样本上. iScience (2022) ncbi
碧迪BD
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s1l
碧迪BD DX5抗体(BD Bioscience, 553857)被用于被用于流式细胞仪在小鼠样本上 (图 s1l). Cell Rep (2022) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 2f
碧迪BD DX5抗体(BD Pharmingen, 553858)被用于被用于流式细胞仪在小鼠样本上 (图 2f). Signal Transduct Target Ther (2021) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 4a, 4b, 4c, 4d
碧迪BD DX5抗体(BD Pharmingen, 553858)被用于被用于流式细胞仪在小鼠样本上 (图 4a, 4b, 4c, 4d). Cell Mol Gastroenterol Hepatol (2021) ncbi
大鼠 单克隆(DX5)
  • 免疫组化; 小鼠; 图 2c
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于免疫组化在小鼠样本上 (图 2c). Blood Adv (2020) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s3j
碧迪BD DX5抗体(BD, 562453)被用于被用于流式细胞仪在小鼠样本上 (图 s3j). Nature (2019) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1a
碧迪BD DX5抗体(BD Bioscience, 553858)被用于被用于流式细胞仪在小鼠样本上 (图 1a). PLoS Biol (2018) ncbi
仓鼠 单克隆(Ha1/29)
  • 流式细胞仪; 小鼠; 图 4d
碧迪BD DX5抗体(BD Biosciences, Ha1/29)被用于被用于流式细胞仪在小鼠样本上 (图 4d). J Virol (2018) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s2b
碧迪BD DX5抗体(BD Biosciences, 553858)被用于被用于流式细胞仪在小鼠样本上 (图 s2b). Cell (2018) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s11
碧迪BD DX5抗体(BD, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s11). Science (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 2d
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 2d). Front Immunol (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 3c
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 3c). Nat Commun (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:50; 图 3b
碧迪BD DX5抗体(BD Pharmingen, DX5)被用于被用于流式细胞仪在小鼠样本上浓度为1:50 (图 3b). Nat Commun (2017) ncbi
仓鼠 单克隆(Ha1/29)
  • 流式细胞仪; 人类; 图 4c
碧迪BD DX5抗体(BD Pharmingen, Ha1/29)被用于被用于流式细胞仪在人类样本上 (图 4c). J Virol (2017) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 4
碧迪BD DX5抗体(BD Pharmingen, 553857)被用于被用于流式细胞仪在小鼠样本上 (图 4). Front Pharmacol (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 4b
碧迪BD DX5抗体(BD Bioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 4b). J Leukoc Biol (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 3b
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 3b). J Immunol (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 1:100; 图 7
碧迪BD DX5抗体(BD Biosciences, 553857)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 7). Nat Commun (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 s2
碧迪BD DX5抗体(BD Bioscience, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 s2). Cell (2016) ncbi
仓鼠 单克隆(Ha1/29)
  • 其他; 大鼠; 图 7
碧迪BD DX5抗体(BD, 559987)被用于被用于其他在大鼠样本上 (图 7). Tissue Eng Part C Methods (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
碧迪BD DX5抗体(BDPharmingen, DX5)被用于被用于流式细胞仪在小鼠样本上. J Thorac Oncol (2016) ncbi
仓鼠 单克隆(Ha1/29)
  • 流式细胞仪; 小鼠; 1:100; 图 1s2
碧迪BD DX5抗体(BD Biosciences, 554999)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 1s2). elife (2016) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 2
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 2). PLoS ONE (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 1
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 1). Sci Rep (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 7
碧迪BD DX5抗体(BD Pharmingen, 553858)被用于被用于流式细胞仪在小鼠样本上 (图 7). Nat Commun (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 2
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 2). J Biol Chem (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
碧迪BD DX5抗体(BD Pharmingen, DX5)被用于被用于流式细胞仪在小鼠样本上. Biochem Biophys Res Commun (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 7
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 7). Clin Sci (Lond) (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 图 3d
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于流式细胞仪在小鼠样本上 (图 3d). J Immunol (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于流式细胞仪在小鼠样本上. J Leukoc Biol (2015) ncbi
仓鼠 单克隆(HM?2)
  • 流式细胞仪; 小鼠
碧迪BD DX5抗体(BD Pharmingen, 557017)被用于被用于流式细胞仪在小鼠样本上. Exp Cell Res (2015) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
碧迪BD DX5抗体(BD Biosciences, DX5)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (2014) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠; 表 1
碧迪BD DX5抗体(BD, DX5)被用于被用于流式细胞仪在小鼠样本上 (表 1). Nat Immunol (2014) ncbi
大鼠 单克隆(DX5)
  • 流式细胞仪; 小鼠
碧迪BD DX5抗体(BD Pharmingen, Dx5)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2014) ncbi
大鼠 单克隆(DX5)
  • 免疫组化; 小鼠
碧迪BD DX5抗体(BD Biosciences Pharmingen, DX5)被用于被用于免疫组化在小鼠样本上. Mol Ther (2014) ncbi
文章列表
  1. Piliponsky A, Sharma K, Quach P, Brokaw A, Nguyen S, Orvis A, et al. Mast cell-derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections. J Clin Invest. 2022;132: pubmed 出版商
  2. Cao S, Hung Y, Wang Y, Chung Y, Qi Y, Ouyang C, et al. Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors. Theranostics. 2022;12:6038-6056 pubmed 出版商
  3. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed 出版商
  4. Madison J, Wilhelm K, Meehan D, Delimont D, Samuelson G, Cosgrove D. Glomerular basement membrane deposition of collagen α1(III) in Alport glomeruli by mesangial filopodia injures podocytes via aberrant signaling through DDR1 and integrin α2β1. J Pathol. 2022;258:26-37 pubmed 出版商
  5. Saxena V, Piao W, Li L, Paluskievicz C, Xiong Y, Simon T, et al. Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses. Cell Rep. 2022;39:110727 pubmed 出版商
  6. Zhang Y, Huo F, Cao Q, Jia R, Huang Q, Wang Z, et al. FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer. J Immunother Cancer. 2022;10: pubmed 出版商
  7. Seung H, Wröbel J, Wadle C, B xfc hler T, Chiang D, Rettkowski J, et al. P2Y12-dependent activation of hematopoietic stem and progenitor cells promotes emergency hematopoiesis after myocardial infarction. Basic Res Cardiol. 2022;117:16 pubmed 出版商
  8. Seitz S, Dreyer T, Stange C, Steiger K, Bräuer R, Scheutz L, et al. CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer. Br J Cancer. 2022;126:1470-1480 pubmed 出版商
  9. Sibilio A, Suñer C, Fernández Alfara M, Martín J, Berenguer A, Calon A, et al. Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development. iScience. 2022;25:103790 pubmed 出版商
  10. Wolpaw A, Grossmann L, Dessau J, Dong M, Aaron B, Brafford P, et al. Epigenetic state determines inflammatory sensing in neuroblastoma. Proc Natl Acad Sci U S A. 2022;119: pubmed 出版商
  11. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed 出版商
  12. Mathä L, Romera Hernandez M, Steer C, Yin Y, Orangi M, Shim H, et al. Migration of Lung Resident Group 2 Innate Lymphoid Cells Link Allergic Lung Inflammation and Liver Immunity. Front Immunol. 2021;12:679509 pubmed 出版商
  13. Van De Velde L, Allen E, Crawford J, Wilson T, Guy C, Russier M, et al. Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells. Cancer Res. 2021;81:5047-5059 pubmed 出版商
  14. Hutton C, Heider F, Blanco Gómez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;: pubmed 出版商
  15. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed 出版商
  16. Lin Q, Rong L, Jia X, Li R, Yu B, Hu J, et al. IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella. Nat Commun. 2021;12:2537 pubmed 出版商
  17. Flamini S, Sergeev P, Viana de Barros Z, Mello T, Biagioli M, Paglialunga M, et al. Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment. Cell Death Dis. 2021;12:421 pubmed 出版商
  18. Chu A, Kok S, TSUI J, Lin M, Aguirre B, Wadehra M. Epithelial membrane protein 2 (Emp2) modulates innate immune cell population recruitment at the maternal-fetal interface. J Reprod Immunol. 2021;145:103309 pubmed 出版商
  19. Shen T, Liu J, Wang C, Rixiati Y, Li S, Cai L, et al. Targeting Erbin in B cells for therapy of lung metastasis of colorectal cancer. Signal Transduct Target Ther. 2021;6:115 pubmed 出版商
  20. Liu J, Wang C, Cheng T, Rixiati Y, Ji C, Deng M, et al. Circadian Clock Disruption Suppresses PDL1+ Intraepithelial B Cells in Experimental Colitis and Colitis-Associated Colorectal Cancer. Cell Mol Gastroenterol Hepatol. 2021;12:251-276 pubmed 出版商
  21. Bielecki P, Riesenfeld S, Hütter J, Torlai Triglia E, Kowalczyk M, Ricardo Gonzalez R, et al. Skin-resident innate lymphoid cells converge on a pathogenic effector state. Nature. 2021;592:128-132 pubmed 出版商
  22. Brownlie D, Doughty Shenton D, Yh Soong D, Nixon C, O Carragher N, M Carlin L, et al. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β. J Immunother Cancer. 2021;9: pubmed 出版商
  23. Chen W, Wu Y, Tsai T, Li R, Lai A, Li L, et al. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis. Theranostics. 2021;11:2594-2611 pubmed 出版商
  24. Suah A, Tran D, Khiew S, Andrade M, Pollard J, Jain D, et al. Pregnancy-induced humoral sensitization overrides T cell tolerance to fetus-matched allografts in mice. J Clin Invest. 2021;131: pubmed 出版商
  25. Yoon S, Song S, Shin J, Kang S, Kim H, You H. Protective Effects of Korean Herbal Remedy against Airway Inflammation in an Allergic Asthma by Suppressing Eosinophil Recruitment and Infiltration in Lung. Antioxidants (Basel). 2020;10: pubmed 出版商
  26. Huang Y, Liang C, Ritz D, Coelho R, Septiadi D, Estermann M, et al. Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis. elife. 2020;9: pubmed 出版商
  27. Mahr B, Pilat N, Granofszky N, Muckenhuber M, Unger L, Weijler A, et al. Distinct roles for major and minor antigen barriers in chimerism-based tolerance under irradiation-free conditions. Am J Transplant. 2021;21:968-977 pubmed 出版商
  28. Vacca F, Chauch C, Jamwal A, Hinchy E, Heieis G, Webster H, et al. A helminth-derived suppressor of ST2 blocks allergic responses. elife. 2020;9: pubmed 出版商
  29. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed 出版商
  30. Zeineldin M, Federico S, Chen X, Fan Y, Xu B, Stewart E, et al. MYCN amplification and ATRX mutations are incompatible in neuroblastoma. Nat Commun. 2020;11:913 pubmed 出版商
  31. Tzeng S, Patel K, Wilson D, Meyer R, Rhodes K, Green J. In situ genetic engineering of tumors for long-lasting and systemic immunotherapy. Proc Natl Acad Sci U S A. 2020;117:4043-4052 pubmed 出版商
  32. Bennewitz M, Tütüncüoğlu E, Gudapati S, Brzoska T, Watkins S, Monga S, et al. P-selectin-deficient mice to study pathophysiology of sickle cell disease. Blood Adv. 2020;4:266-273 pubmed 出版商
  33. Asrat S, Kaur N, Liu X, Ben L, Kajimura D, Murphy A, et al. Chronic allergen exposure drives accumulation of long-lived IgE plasma cells in the bone marrow, giving rise to serological memory. Sci Immunol. 2020;5: pubmed 出版商
  34. Guo C, Allen B, Hiam K, Dodd D, Van Treuren W, Higginbottom S, et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics. Science. 2019;366: pubmed 出版商
  35. Tsao L, Crosby E, Trotter T, Agarwal P, Hwang B, Acharya C, et al. CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis. JCI Insight. 2019;4: pubmed 出版商
  36. Nagai J, Balestrieri B, Fanning L, Kyin T, Cirka H, Lin J, et al. P2Y6 signaling in alveolar macrophages prevents leukotriene-dependent type 2 allergic lung inflammation. J Clin Invest. 2019;129:5169-5186 pubmed 出版商
  37. Benechet A, De Simone G, Di Lucia P, Cilenti F, Barbiera G, Le Bert N, et al. Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming. Nature. 2019;574:200-205 pubmed 出版商
  38. Niemann J, Woller N, Brooks J, Fleischmann Mundt B, Martin N, Kloos A, et al. Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy. Nat Commun. 2019;10:3236 pubmed 出版商
  39. Knox T, Sahakian E, Banik D, Hadley M, Palmer E, Noonepalle S, et al. Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells. Sci Rep. 2019;9:6136 pubmed 出版商
  40. Jeppesen D, Fenix A, Franklin J, Higginbotham J, Zhang Q, Zimmerman L, et al. Reassessment of Exosome Composition. Cell. 2019;177:428-445.e18 pubmed 出版商
  41. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed 出版商
  42. Davies A, Kim H, González Cano R, Choi J, Back S, Roh S, et al. Natural Killer Cells Degenerate Intact Sensory Afferents following Nerve Injury. Cell. 2019;176:716-728.e18 pubmed 出版商
  43. Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, et al. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature. 2018;562:605-609 pubmed 出版商
  44. Albrengues J, Shields M, Ng D, Park C, Ambrico A, Poindexter M, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361: pubmed 出版商
  45. Casey A, Sinha A, Singhania R, Livingstone J, Waterhouse P, Tharmapalan P, et al. Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities. J Cell Biol. 2018;217:2951-2974 pubmed 出版商
  46. Abel A, Tiwari A, Gerbec Z, Siebert J, Yang C, Schloemer N, et al. IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells. Front Immunol. 2018;9:1168 pubmed 出版商
  47. Jogdand G, Sengupta S, Bhattacharya G, Singh S, Barik P, Devadas S. Inducible Costimulator Expressing T Cells Promote Parasitic Growth During Blood Stage Plasmodium berghei ANKA Infection. Front Immunol. 2018;9:1041 pubmed 出版商
  48. Wang Y, Dong W, Zhang Y, Caligiuri M, Yu J. Dependence of innate lymphoid cell 1 development on NKp46. PLoS Biol. 2018;16:e2004867 pubmed 出版商
  49. Dipiazza A, Laniewski N, Rattan A, Topham D, Miller J, Sant A. CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection. J Virol. 2018;92: pubmed 出版商
  50. Sadana P, Geyer R, Pezoldt J, Helmsing S, Huehn J, Hust M, et al. The invasin D protein from Yersinia pseudotuberculosis selectively binds the Fab region of host antibodies and affects colonization of the intestine. J Biol Chem. 2018;293:8672-8690 pubmed 出版商
  51. Sockolosky J, Trotta E, Parisi G, Picton L, Su L, Le A, et al. Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science. 2018;359:1037-1042 pubmed 出版商
  52. Lee Y, Lee J, Jang Y, Seo S, Chang J, Seong B. Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine. Front Microbiol. 2018;9:83 pubmed 出版商
  53. Böttcher J, Bonavita E, Chakravarty P, Blees H, Cabeza Cabrerizo M, Sammicheli S, et al. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. Cell. 2018;172:1022-1037.e14 pubmed 出版商
  54. Engblom C, Pfirschke C, Zilionis R, da Silva Martins J, Bos S, Courties G, et al. Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils. Science. 2017;358: pubmed 出版商
  55. Glasner A, Isaacson B, Viukov S, Neuman T, Friedman N, Mandelboim M, et al. Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression. Sci Rep. 2017;7:13090 pubmed 出版商
  56. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed 出版商
  57. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed 出版商
  58. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed 出版商
  59. Schuetz C, Lee K, Scott R, Kojima L, Washburn L, Liu L, et al. Regulatory B Cell-Dependent Islet Transplant Tolerance Is Also Natural Killer Cell Dependent. Am J Transplant. 2017;17:1656-1662 pubmed 出版商
  60. Baranek T, Morello E, Valayer A, Aimar R, Bréa D, Henry C, et al. FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection. Front Immunol. 2017;8:123 pubmed 出版商
  61. Cuccarese M, Dubach J, Pfirschke C, Engblom C, Garris C, Miller M, et al. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. Nat Commun. 2017;8:14293 pubmed 出版商
  62. Yanagita T, Murata Y, Tanaka D, Motegi S, Arai E, Daniwijaya E, et al. Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy. JCI Insight. 2017;2:e89140 pubmed 出版商
  63. Zhu J, Cifuentes H, Reynolds J, Lamba D. Immunosuppression via Loss of IL2rγ Enhances Long-Term Functional Integration of hESC-Derived Photoreceptors in the Mouse Retina. Cell Stem Cell. 2017;20:374-384.e5 pubmed 出版商
  64. van der Weyden L, Arends M, Campbell A, Bald T, Wardle Jones H, Griggs N, et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature. 2017;541:233-236 pubmed 出版商
  65. Fujikura D, Ikesue M, Endo T, Chiba S, Higashi H, Uede T. Death receptor 6 contributes to autoimmunity in lupus-prone mice. Nat Commun. 2017;8:13957 pubmed 出版商
  66. von Moltke J, O Leary C, Barrett N, Kanaoka Y, Austen K, Locksley R. Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med. 2017;214:27-37 pubmed 出版商
  67. Ohs I, Van Den Broek M, Nussbaum K, MUNZ C, Arnold S, Quezada S, et al. Interleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis. Nat Commun. 2016;7:13708 pubmed 出版商
  68. Tripathi D, Venkatasubramanian S, Cheekatla S, Paidipally P, Welch E, Tvinnereim A, et al. A TLR9 agonist promotes IL-22-dependent pancreatic islet allograft survival in type 1 diabetic mice. Nat Commun. 2016;7:13896 pubmed 出版商
  69. Bieber K, Witte M, Sun S, Hundt J, Kalies K, Dräger S, et al. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita. Sci Rep. 2016;6:38357 pubmed 出版商
  70. Sektioglu I, Carretero R, Bulbuc N, Bald T, Tüting T, Rudensky A, et al. Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. Cancer Res. 2017;77:291-302 pubmed 出版商
  71. Meng C, Li Z, Fang W, Song Z, Yang D, Li D, et al. Cytochrome P450 26A1 modulates natural killer cells in mouse early pregnancy. J Cell Mol Med. 2017;21:697-710 pubmed 出版商
  72. Srivastava R, Khan A, Garg S, Syed S, Furness J, Vahed H, et al. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocula. J Virol. 2017;91: pubmed 出版商
  73. Coleman C, Sisk J, Halasz G, Zhong J, Beck S, Matthews K, et al. CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome. J Virol. 2017;91: pubmed 出版商
  74. Teng O, Chen S, Hsu T, Sia S, Cole S, Valkenburg S, et al. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo. J Virol. 2017;91: pubmed 出版商
  75. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed 出版商
  76. Jackson Jones L, Duncan S, Magalhaes M, Campbell S, Maizels R, McSorley H, et al. Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammation. Nat Commun. 2016;7:12651 pubmed 出版商
  77. Guo H, Cranert S, Lu Y, Zhong M, Zhang S, Chen J, et al. Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1. J Exp Med. 2016;213:2187-207 pubmed 出版商
  78. Huang Y, Li P, Wang J, Zhou H, Yang Z, Yang R, et al. Inhibition of Sophocarpine on Poly I: C/D-GalN-Induced Immunological Liver Injury in Mice. Front Pharmacol. 2016;7:256 pubmed 出版商
  79. Yoon J, Leyva Castillo J, Wang G, Galand C, Oyoshi M, Kumar L, et al. IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. J Exp Med. 2016;213:2147-66 pubmed 出版商
  80. Melton D, Roberts A, Wang H, Sarwar Z, Wetzel M, Wells J, et al. Absence of CCR2 results in an inflammaging environment in young mice with age-independent impairments in muscle regeneration. J Leukoc Biol. 2016;100:1011-1025 pubmed
  81. Chow K, Delconte R, Huntington N, Tarlinton D, Sutherland R, Zhan Y, et al. Innate Allorecognition Results in Rapid Accumulation of Monocyte-Derived Dendritic Cells. J Immunol. 2016;197:2000-8 pubmed 出版商
  82. Keil M, Sonner J, Lanz T, Oezen I, Bunse T, Bittner S, et al. General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation. J Neuroimmunol. 2016;297:117-26 pubmed 出版商
  83. Allison K, Sajti E, Collier J, Gosselin D, Troutman T, Stone E, et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. elife. 2016;5: pubmed 出版商
  84. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed 出版商
  85. Uto T, Fukaya T, Takagi H, Arimura K, Nakamura T, Kojima N, et al. Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity. Nat Commun. 2016;7:11273 pubmed 出版商
  86. Xiong H, Keith J, Samilo D, Carter R, Leiner I, Pamer E. Innate Lymphocyte/Ly6C(hi) Monocyte Crosstalk Promotes Klebsiella Pneumoniae Clearance. Cell. 2016;165:679-89 pubmed 出版商
  87. Stabler C, Caires L, Mondrinos M, Marcinkiewicz C, Lazarovici P, Wolfson M, et al. Enhanced Re-Endothelialization of Decellularized Rat Lungs. Tissue Eng Part C Methods. 2016;22:439-50 pubmed 出版商
  88. Pelly V, Kannan Y, Coomes S, Entwistle L, Rückerl D, Seddon B, et al. IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol. 2016;9:1407-1417 pubmed 出版商
  89. Ghosh S, Shinogle H, Galeva N, Dobrowsky R, Blagg B. Endoplasmic Reticulum-resident Heat Shock Protein 90 (HSP90) Isoform Glucose-regulated Protein 94 (GRP94) Regulates Cell Polarity and Cancer Cell Migration by Affecting Intracellular Transport. J Biol Chem. 2016;291:8309-23 pubmed 出版商
  90. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed 出版商
  91. Azpilikueta A, Agorreta J, Labiano S, Pérez Gracia J, Sánchez Paulete A, Aznar M, et al. Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies. J Thorac Oncol. 2016;11:524-36 pubmed 出版商
  92. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed 出版商
  93. Theodosiou M, Widmaier M, Böttcher R, Rognoni E, Veelders M, Bharadwaj M, et al. Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin. elife. 2016;5:e10130 pubmed 出版商
  94. De Franceschi N, Arjonen A, Elkhatib N, Denessiouk K, Wrobel A, Wilson T, et al. Selective integrin endocytosis is driven by interactions between the integrin α-chain and AP2. Nat Struct Mol Biol. 2016;23:172-9 pubmed 出版商
  95. Everts B, Tussiwand R, Dreesen L, Fairfax K, Huang S, Smith A, et al. Migratory CD103+ dendritic cells suppress helminth-driven type 2 immunity through constitutive expression of IL-12. J Exp Med. 2016;213:35-51 pubmed 出版商
  96. Okada K, Sato S, Sato A, Mandelboim O, Yamasoba T, Kiyono H. Identification and Analysis of Natural Killer Cells in Murine Nasal Passages. PLoS ONE. 2015;10:e0142920 pubmed 出版商
  97. Zhang Z, Wu N, Lu Y, Davidson D, Colonna M, Veillette A. DNAM-1 controls NK cell activation via an ITT-like motif. J Exp Med. 2015;212:2165-82 pubmed 出版商
  98. Hoshino A, Costa Silva B, Shen T, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329-35 pubmed 出版商
  99. Kim J, Phan T, Nguyen V, Dinh Vu H, Zheng J, Yun M, et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015;5:1328-42 pubmed 出版商
  100. Patel M, Jacobson B, Ji Y, Drees J, Tang S, Xiong K, et al. Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer. Oncotarget. 2015;6:33165-77 pubmed 出版商
  101. Wilson K, Goding S, Neely H, Harris K, Antony P. Depletion of B220+NK1.1+ cells enhances the rejection of established melanoma by tumor-specific CD4+ T cells. Oncoimmunology. 2015;4:e1019196 pubmed
  102. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed 出版商
  103. Smith K, Filbey K, Reynolds L, Hewitson J, Harcus Y, Boon L, et al. Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths. Mucosal Immunol. 2016;9:428-43 pubmed 出版商
  104. Hossain M, Qadri S, Xu N, Su Y, Cayabyab F, Heit B, et al. Endothelial LSP1 Modulates Extravascular Neutrophil Chemotaxis by Regulating Nonhematopoietic Vascular PECAM-1 Expression. J Immunol. 2015;195:2408-16 pubmed 出版商
  105. Littwitz Salomon E, Akhmetzyanova I, Vallet C, Francois S, Dittmer U, Gibbert K. Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology. 2015;12:66 pubmed 出版商
  106. Jovicic N, Jeftic I, Jovanovic I, Radosavljevic G, Arsenijevic N, Lukic M, et al. Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding. PLoS ONE. 2015;10:e0134089 pubmed 出版商
  107. Fujimura N, Xu B, Dalman J, Deng H, Aoyama K, Dalman R. CCR2 inhibition sequesters multiple subsets of leukocytes in the bone marrow. Sci Rep. 2015;5:11664 pubmed 出版商
  108. Vettorazzi S, Bode C, Dejager L, Frappart L, Shelest E, Klaßen C, et al. Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. Nat Commun. 2015;6:7796 pubmed 出版商
  109. Vogel A, Brown D. Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells. Front Immunol. 2015;6:327 pubmed 出版商
  110. Kim M, Taparowsky E, Kim C. Retinoic Acid Differentially Regulates the Migration of Innate Lymphoid Cell Subsets to the Gut. Immunity. 2015;43:107-19 pubmed 出版商
  111. Singh N, Kotla S, Dyukova E, Traylor J, Orr A, Chernoff J, et al. Disruption of p21-activated kinase 1 gene diminishes atherosclerosis in apolipoprotein E-deficient mice. Nat Commun. 2015;6:7450 pubmed 出版商
  112. Joshi P, Waterhouse P, Kannan N, Narala S, Fang H, Di Grappa M, et al. RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1. Stem Cell Reports. 2015;5:31-44 pubmed 出版商
  113. Huang H, Rajanbabu V, Pan C, Chan Y, Chen J, Wu C. Enhanced Control of Bladder-Associated Tumors Using Shrimp Anti-Lipopolysaccharide Factor (SALF) Antimicrobial Peptide as a Cancer Vaccine Adjuvant in Mice. Mar Drugs. 2015;13:3241-58 pubmed 出版商
  114. Di C, Lin X, Zhang Y, Zhong W, Yuan Y, Zhou T, et al. Basophil-associated OX40 ligand participates in the initiation of Th2 responses during airway inflammation. J Biol Chem. 2015;290:12523-36 pubmed 出版商
  115. Nishikado H, Fujimura T, Taka H, Mineki R, Ogawa H, Okumura K, et al. Cysteine protease antigens cleave CD123, the α subunit of murine IL-3 receptor, on basophils and suppress IL-3-mediated basophil expansion. Biochem Biophys Res Commun. 2015;460:261-6 pubmed 出版商
  116. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  117. Wensveen F, Jelenčić V, Valentić S, Å estan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed 出版商
  118. Drees J, Mertensotto M, Liu G, Panyam J, Leonard A, Augustin L, et al. Attenuated Salmonella enterica Typhimurium reduces tumor burden in an autochthonous breast cancer model. Anticancer Res. 2015;35:843-9 pubmed
  119. Wirsdörfer F, Bangen J, Pastille E, Hansen W, Flohé S. Breaking the co-operation between bystander T-cells and natural killer cells prevents the development of immunosuppression after traumatic skeletal muscle injury in mice. Clin Sci (Lond). 2015;128:825-38 pubmed 出版商
  120. Briercheck E, Trotta R, Chen L, Hartlage A, Cole J, Cole T, et al. PTEN is a negative regulator of NK cell cytolytic function. J Immunol. 2015;194:1832-40 pubmed 出版商
  121. Spada R, Rojas J, Pérez Yagüe S, Mulens V, Cannata Ortiz P, Bragado R, et al. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery. J Leukoc Biol. 2015;97:583-98 pubmed 出版商
  122. Khaled W, Choon Lee S, Stingl J, Chen X, Raza Ali H, Rueda O, et al. BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells. Nat Commun. 2015;6:5987 pubmed 出版商
  123. Shindo Y, Unsinger J, Burnham C, Green J, Hotchkiss R. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock. 2015;43:334-43 pubmed 出版商
  124. Krishnamoorthy N, Burkett P, Dalli J, Abdulnour R, Colas R, Ramon S, et al. Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation. J Immunol. 2015;194:863-7 pubmed 出版商
  125. Elloumi Hannachi I, García J, Shekeran A, García A. Contributions of the integrin β1 tail to cell adhesive forces. Exp Cell Res. 2015;332:212-22 pubmed 出版商
  126. Dang V, Tanabe K, Tanaka Y, Tokumoto N, Misumi T, Saeki Y, et al. Fasting enhances TRAIL-mediated liver natural killer cell activity via HSP70 upregulation. PLoS ONE. 2014;9:e110748 pubmed 出版商
  127. Tassi I, Claudio E, Wang H, Tang W, Ha H, Saret S, et al. The NF-κB regulator Bcl-3 governs dendritic cell antigen presentation functions in adaptive immunity. J Immunol. 2014;193:4303-11 pubmed 出版商
  128. Larsen J, Dall M, Antvorskov J, Weile C, Engkilde K, Josefsen K, et al. Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion. Eur J Immunol. 2014;44:3056-67 pubmed 出版商
  129. Madireddi S, Eun S, Lee S, Nemčovičová I, Mehta A, Zajonc D, et al. Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. J Exp Med. 2014;211:1433-48 pubmed 出版商
  130. Weston W, Zayas J, Perez R, George J, Jurecic R. Dynamic equilibrium of heterogeneous and interconvertible multipotent hematopoietic cell subsets. Sci Rep. 2014;4:5199 pubmed 出版商
  131. Weber G, Chousterman B, Hilgendorf I, Robbins C, Theurl I, Gerhardt L, et al. Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. J Exp Med. 2014;211:1243-56 pubmed 出版商
  132. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed 出版商
  133. Brenndörfer E, Brass A, Karthe J, Ahlen G, Bode J, Sallberg M. Cleavage of the T cell protein tyrosine phosphatase by the hepatitis C virus nonstructural 3/4A protease induces a Th1 to Th2 shift reversible by ribavirin therapy. J Immunol. 2014;192:1671-80 pubmed 出版商
  134. Wickström S, Oberg L, Kärre K, Johansson M. A genetic defect in mice that impairs missing self recognition despite evidence for normal maturation and MHC class I-dependent education of NK cells. J Immunol. 2014;192:1577-86 pubmed 出版商
  135. Weng T, Huang S, Yen M, Lin C, Chen Y, Lin C, et al. A novel cancer therapeutic using thrombospondin 1 in dendritic cells. Mol Ther. 2014;22:292-302 pubmed 出版商
  136. Wu X, Satpathy A, Kc W, Liu P, Murphy T, Murphy K. Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo. PLoS ONE. 2013;8:e64800 pubmed 出版商
  137. Loebbermann J, Schnoeller C, Thornton H, Durant L, Sweeney N, Schuijs M, et al. IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS ONE. 2012;7:e32371 pubmed 出版商
  138. Liang H, Reinhardt R, Bando J, Sullivan B, Ho I, Locksley R. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol. 2011;13:58-66 pubmed 出版商
  139. Yan S, Wang L, Liu N, Wang Y, Chu Y. Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis. Immunol Cell Biol. 2012;90:421-8 pubmed 出版商
  140. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed 出版商
  141. Kim S, Prout M, Ramshaw H, Lopez A, LeGros G, Min B. Cutting edge: basophils are transiently recruited into the draining lymph nodes during helminth infection via IL-3, but infection-induced Th2 immunity can develop without basophil lymph node recruitment or IL-3. J Immunol. 2010;184:1143-7 pubmed 出版商
  142. Zou Y, Chen T, Han M, Wang H, Yan W, Song G, et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol. 2010;184:466-75 pubmed 出版商
  143. Fahl S, Crittenden R, Allman D, Bender T. c-Myb is required for pro-B cell differentiation. J Immunol. 2009;183:5582-92 pubmed 出版商
  144. Huntington N, Legrand N, Alves N, Jaron B, Weijer K, Plet A, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med. 2009;206:25-34 pubmed 出版商
  145. Kanwar N, Fayyazi A, Backofen B, Nitsche M, Dressel R, von Mollard G. Thymic alterations in mice deficient for the SNARE protein VAMP8/endobrevin. Cell Tissue Res. 2008;334:227-42 pubmed 出版商
  146. Zhang J, Kawashima N, Suda H, Nakano Y, Takano Y, Azuma M. The existence of CD11c+ sentinel and F4/80+ interstitial dendritic cells in dental pulp and their dynamics and functional properties. Int Immunol. 2006;18:1375-84 pubmed
  147. Rubinstein M, Kovar M, Purton J, Cho J, Boyman O, Surh C, et al. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}. Proc Natl Acad Sci U S A. 2006;103:9166-71 pubmed
  148. Fallon P, Ballantyne S, Mangan N, Barlow J, Dasvarma A, Hewett D, et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med. 2006;203:1105-16 pubmed
  149. Nakae S, Suto H, Kakurai M, Sedgwick J, Tsai M, Galli S. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci U S A. 2005;102:6467-72 pubmed